drugset / Trial / NCT02597829
Does Clinical Response Correlate With Serum Certolizumab Levels?
NaSingle-groupOpen-labelTreatment
Summary
A prospective open label trial of adult patients with active Crohn's disease to determine if plasma concentrations of certolizumab pegol correlate to mucosal healing.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-05
- Completion
- 2018-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Certolizumab Pegol | Protein / enzyme biologic | — | Subcutaneous |